Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUSP3 | P51452 | 12/20 | 0.50 |
| ▸ | CDC25A | P30304 | 10/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.47 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.39 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.39 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.39 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.39 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.39 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.39 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.39 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15874389 | 0.77 | DUSP3 (0.57) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 | |
| SCHEMBL6511122 | 0.75 | DUSP3 (0.58) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 | |
| SCHEMBL30236154 | 0.72 | DUSP3 (0.56) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 | |
| SCHEMBL13455165 | 0.72 | DUSP3 (0.56) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 | |
| SCHEMBL19214454 | 0.72 | DUSP3 (0.56) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 | |
| SCHEMBL15874368 | 0.71 | DUSP3 (0.48) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 | |
| SCHEMBL17273933 | 0.70 | DUSP3 (0.47) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 | |
| SCHEMBL15874282 | 0.70 | DUSP3 (0.47) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 | |
| SCHEMBL19214464 | 0.70 | DUSP3 (0.47) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 | |
| SCHEMBL15886567 | 0.69 | DUSP3 (0.46) | DUSP3CDC25APTPN1MAPKAPK2CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113853432-B | Novel polypeptides for producing patchoulol and/or drimenol compounds | 弗门尼舍有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-113853432-B | Novel polypeptides for producing patchoulol and/or drimenol compounds | 弗门尼舍有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12612653-B2 | Polypeptides for producing albicanol and/or drimenol compounds | FIRMENICH SA (CH) | 2026-04-28 | — | — | US | disclosed |
| US-20240376502-A1 | NOVEL POLYPEPTIDES FOR PRODUCING ALBICANOL AND/OR DRIMENOL COMPOUNDS | FIRMENICH SA (CH) | 2024-11-14 | — | — | US | disclosed |
| CN-112789354-B | Process for producing a drimenoalkyl acetate compound | 弗门尼舍有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-110691850-B | Method for producing patchoulol and/or drimenol | 弗门尼舍有限公司 | 2024-07-02 | — | — | CN | disclosed |
| EP-4013862-A2 | NOVEL POLYPEPTIDES FOR PRODUCING ALBICANOL AND/OR DRIMENOL COMPOUNDS | Firmenich SA (CH) | 2022-06-22 | — | — | EP | disclosed |
| CN-113853432-A | Novel polypeptides for producing orexin and/or drimenol compounds | 弗门尼舍有限公司 | 2021-12-28 | — | — | CN | disclosed |
| WO-2021105236-A2 | NOVEL POLYPEPTIDES FOR PRODUCING ALBICANOL AND/OR DRIMENOL COMPOUNDS | FIRMENICH SA (CH) | 2021-06-03 | — | — | WO | disclosed |
| CN-110691850-A | Method for producing orexin and/or drimenol | 弗门尼舍有限公司 | 2020-01-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612653-B2 | Polypeptides for producing albicanol and/or drimenol compounds | FDPS, DHPS, HDHD5 | DUSP3 128/4885CDC25A 475/4885PTPN1 2711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.